4//SEC Filing
GOLDSTEIN ALLAN L 4
Accession 0000914190-21-000192
CIK 0000707511other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 4:34 PM ET
Size
23.6 KB
Accession
0000914190-21-000192
Insider Transaction Report
Form 4
GOLDSTEIN ALLAN L
Director
Transactions
- Purchase
Common Stock
2021-06-30$0.20/sh+125,000$25,000→ 1,637,793 total - Purchase
Series A Common Stock Warrant (right to buy)
2021-06-30+93,750→ 93,750 totalExercise: $0.24From: 2021-06-30Exp: 2023-06-30→ Common Stock (93,750 underlying) - Purchase
Series B Common Stock Warrant (right to buy)
2021-06-30+93,750→ 93,750 totalExercise: $0.28From: 2021-06-30Exp: 2026-06-30→ Common Stock (93,750 underlying)
Holdings
- 250,000
Stock Option (right to buy)
Exercise: $0.36Exp: 2022-06-30→ Common Stock (250,000 underlying) - 200,000
Stock Option (right to buy)
Exercise: $0.64Exp: 2023-03-16→ Common Stock (200,000 underlying) Convertible Promissory Note (right to buy)
Exercise: $0.12From: 2019-02-27Exp: 2024-02-27→ Common Stock (20,833 underlying)Convertible Promissory Note (right to buy)
Exercise: $0.12From: 2019-05-13Exp: 2024-05-13→ Common Stock (20,833 underlying)- 15,625
Common Stock Warrant (right to buy)
Exercise: $0.18From: 2019-08-27Exp: 2024-02-27→ Common Stock (15,625 underlying) - 15,625
Common Stock Warrant (right to buy)
Exercise: $0.18From: 2019-11-13Exp: 2024-05-13→ Common Stock (15,625 underlying) - 10,440
Common Stock Warrant (right to buy)
Exercise: $0.45From: 2021-04-15Exp: 2025-10-15→ Common Stock (10,440 underlying) - 150,000
Stock Option (right to buy)
Exercise: $0.28Exp: 2027-09-01→ Common Stock (150,000 underlying) - 410,000
Stock Option (right to buy)
Exercise: $0.21Exp: 2029-05-15→ Common Stock (410,000 underlying) Convertible Promissory Note (right to buy)
Exercise: $0.36From: 2020-10-15Exp: 2025-10-15→ Common Stock (13,920 underlying)- 250,000
Stock Option (right to buy)
Exercise: $0.21Exp: 2028-07-17→ Common Stock (250,000 underlying) - 400,000
Stock Option (right to buy)
Exercise: $0.30Exp: 2030-06-10→ Common Stock (400,000 underlying)
Footnotes (4)
- [F1]100% vested.
- [F2]62,500 shares vest on each of 7/17/18, 7/17/19, 7/17/20 and 7/17/21.
- [F3]102,500 shares vest on each of 5/15/19, 5/15/20, 5/15/21 and 5/15/22.
- [F4]100,000 shares vest on each of 6/10/20, 6/10/21, 6/10/22 and 6/10/23.
Documents
Issuer
REGENERX BIOPHARMACEUTICALS INC
CIK 0000707511
Entity typeother
Related Parties
1- filerCIK 0000905390
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 4:34 PM ET
- Size
- 23.6 KB